152 related articles for article (PubMed ID: 29107615)
1. The natural bile acid surfactant sodium taurocholate (NaTC) as a coformer in coamorphous systems: Enhanced physical stability and dissolution behavior of coamorphous drug-NaTc systems.
Gniado K; MacFhionnghaile P; McArdle P; Erxleben A
Int J Pharm; 2018 Jan; 535(1-2):132-139. PubMed ID: 29107615
[TBL] [Abstract][Full Text] [Related]
2. In silico and in vitro investigation of bile salts as coformers for edaravone coamorphous dispersion- Part I.
Patel D; Wairkar S
Chem Phys Lipids; 2023 Jul; 253():105302. PubMed ID: 37031754
[TBL] [Abstract][Full Text] [Related]
3. Coamorphous drug systems: enhanced physical stability and dissolution rate of indomethacin and naproxen.
Löbmann K; Laitinen R; Grohganz H; Gordon KC; Strachan C; Rades T
Mol Pharm; 2011 Oct; 8(5):1919-28. PubMed ID: 21815614
[TBL] [Abstract][Full Text] [Related]
4. The influence of co-formers on the dissolution rates of co-amorphous sulfamerazine/excipient systems.
Gniado K; Löbmann K; Rades T; Erxleben A
Int J Pharm; 2016 May; 504(1-2):20-6. PubMed ID: 26992818
[TBL] [Abstract][Full Text] [Related]
5. Preparation and characterization of spray-dried co-amorphous drug-amino acid salts.
Jensen KT; Blaabjerg LI; Lenz E; Bohr A; Grohganz H; Kleinebudde P; Rades T; Löbmann K
J Pharm Pharmacol; 2016 May; 68(5):615-24. PubMed ID: 26245703
[TBL] [Abstract][Full Text] [Related]
6. Coamorphous Active Pharmaceutical Ingredient-Small Molecule Mixtures: Considerations in the Choice of Coformers for Enhancing Dissolution and Oral Bioavailability.
Newman A; Reutzel-Edens SM; Zografi G
J Pharm Sci; 2018 Jan; 107(1):5-17. PubMed ID: 28989014
[TBL] [Abstract][Full Text] [Related]
7. Bio-relevant media to assess drug permeability: sodium taurocholate and lecithin combination or crude bile?
Berginc K; Trontelj J; Kristl A
Int J Pharm; 2012 Jun; 429(1-2):22-30. PubMed ID: 22449411
[TBL] [Abstract][Full Text] [Related]
8. Enhanced Physical Stability and Synchronized Release of Febuxostat and Indomethacin in Coamorphous Solids.
Moinuddin SM; Shi Q; Tao J; Guo M; Zhang J; Xue Q; Ruan S; Cai T
AAPS PharmSciTech; 2020 Jan; 21(2):41. PubMed ID: 31898765
[TBL] [Abstract][Full Text] [Related]
9. Incorporation of Complexation into a Coamorphous System Dramatically Enhances Dissolution and Eliminates Gelation of Amorphous Lurasidone Hydrochloride.
Heng W; Su M; Cheng H; Shen P; Liang S; Zhang L; Wei Y; Gao Y; Zhang J; Qian S
Mol Pharm; 2020 Jan; 17(1):84-97. PubMed ID: 31794225
[TBL] [Abstract][Full Text] [Related]
10. Investigation of the formation of drug-drug cocrystals and coamorphous systems of the antidiabetic drug gliclazide.
Aljohani M; MacFhionnghaile P; McArdle P; Erxleben A
Int J Pharm; 2019 Apr; 561():35-42. PubMed ID: 30802549
[TBL] [Abstract][Full Text] [Related]
11. Dual Functionality of Bile Acid: Physical Stabilization of Drugs in the Amorphous Form and Solubility Enhancement in Solution.
Lalge R; Kaur N; Duggirala NK; Suryanarayanan R
Mol Pharm; 2022 Jul; 19(7):2595-2606. PubMed ID: 35687125
[TBL] [Abstract][Full Text] [Related]
12. Quantitative estimation of the effects of bile salt surfactant systems on insulin stability and permeability in the rat intestine using a mass balance model.
Lane ME; O'driscoll CM; Corrigan OI
J Pharm Pharmacol; 2005 Feb; 57(2):169-75. PubMed ID: 15720779
[TBL] [Abstract][Full Text] [Related]
13. Amino acids as co-amorphous stabilizers for poorly water soluble drugs--Part 1: preparation, stability and dissolution enhancement.
Löbmann K; Grohganz H; Laitinen R; Strachan C; Rades T
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):873-81. PubMed ID: 23537574
[TBL] [Abstract][Full Text] [Related]
14. Formation Mechanism of Coamorphous Drug-Amino Acid Mixtures.
Jensen KT; Larsen FH; Cornett C; Löbmann K; Grohganz H; Rades T
Mol Pharm; 2015 Jul; 12(7):2484-92. PubMed ID: 26057950
[TBL] [Abstract][Full Text] [Related]
15. Coamorphous Loratadine-Citric Acid System with Enhanced Physical Stability and Bioavailability.
Wang J; Chang R; Zhao Y; Zhang J; Zhang T; Fu Q; Chang C; Zeng A
AAPS PharmSciTech; 2017 Oct; 18(7):2541-2550. PubMed ID: 28224393
[TBL] [Abstract][Full Text] [Related]
16. Mechanistic insights into the crystallization of coamorphous drug systems.
Heng W; Song Y; Luo M; Hu E; Wei Y; Gao Y; Pang Z; Zhang J; Qian S
J Control Release; 2023 Feb; 354():489-502. PubMed ID: 36646287
[TBL] [Abstract][Full Text] [Related]
17. Formation of a Stable Co-Amorphous System for a Brick Dust Molecule by Utilizing Sodium Taurocholate with High Glass Transition Temperature.
Aikawa S; Tanaka H; Ueda H; Maruyama M; Higaki K
Pharmaceutics; 2022 Dec; 15(1):. PubMed ID: 36678713
[TBL] [Abstract][Full Text] [Related]
18. Probing the molecular interactions between pharmaceutical polymeric carriers and bile salts in simulated gastrointestinal fluids using NMR spectroscopy.
Pigliacelli C; Belton P; Wilde P; Qi S
J Colloid Interface Sci; 2019 Sep; 551():147-154. PubMed ID: 31075629
[TBL] [Abstract][Full Text] [Related]
19. Spectroscopic Investigation of the Interaction of the Anticancer Drug Mitoxantrone with Sodium Taurodeoxycholate (NaTDC) and Sodium Taurocholate (NaTC) Bile Salts.
Enache M; Toader AM; Neacsu V; Ionita G; Enache MI
Molecules; 2017 Jun; 22(7):. PubMed ID: 28657593
[TBL] [Abstract][Full Text] [Related]
20. Effect of drug-coformer interactions on drug dissolution from a coamorphous in mesoporous silica.
Budiman A; Higashi K; Ueda K; Moribe K
Int J Pharm; 2021 May; 600():120492. PubMed ID: 33744448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
